Ovintiv (OVV) CEO trades 10,373 SARs, ends with 234,689 shares owned

Rhea-AI Filing Summary

Ovintiv Inc. reported an insider stock transaction by its President & CEO, who is also a director. On 12/04/2025, the executive exercised stock appreciation rights to acquire 10,373 shares of Ovintiv common stock at an exercise price of $35.80 per share. These rights were originally granted on 03/08/2019 and were scheduled to expire on 03/08/2026, and the exercise reduced the remaining balance of these derivative awards to zero.

On the same date, the executive sold 10,323 Ovintiv common shares at a price of $42.32 per share. After these transactions, the executive directly held 234,689 shares of Ovintiv common stock. Each stock appreciation right represented the economic equivalent of one share of Ovintiv common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCracken Brendan Michael

(Last) (First) (Middle)

C/O 370 17TH STREET, SUITE 1700

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ovintiv Inc. [ OVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/04/2025		M		10,373	A	$35.8	245,062	D
Common Stock	12/04/2025		D		10,323	D	$42.32	234,689	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights(1)	$35.8	12/04/2025		M			10,373	03/08/2019	03/08/2026	Common Stock	10,373	$0	0	D

Explanation of Responses:

1. Each Stock Appreciation Right is the economic equivalent of one share of Ovintiv Inc. common stock.

	/s/ Dawna Gibb, by Power of Attorney	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ovintiv Inc. (OVV) disclose for its CEO?

The President & CEO of Ovintiv Inc., who is also a director, exercised 10,373 stock appreciation rights on 12/04/2025, receiving the equivalent number of common shares, and sold 10,323 common shares the same day.

How many Ovintiv (OVV) shares does the CEO own after the reported transaction?

Following the transactions on 12/04/2025, the executive directly beneficially owned 234,689 shares of Ovintiv common stock.

At what prices did the Ovintiv (OVV) CEO exercise rights and sell shares?

The stock appreciation rights were exercised at an exercise price of $35.80 per share equivalent, and 10,323 Ovintiv common shares were sold at a price of $42.32 per share.

What are the details of the Ovintiv (OVV) stock appreciation rights exercised?

The executive exercised 10,373 stock appreciation rights on 12/04/2025. These rights were exercisable since 03/08/2019, had an exercise price of $35.80, were scheduled to expire on 03/08/2026, and each right was equivalent to one share of common stock.

Does the Ovintiv (OVV) CEO still hold the stock appreciation rights after this transaction?

No. After exercising 10,373 stock appreciation rights on 12/04/2025, the number of such derivative securities beneficially owned was reduced to 0.

What role does the reporting person hold at Ovintiv Inc. (OVV)?

The reporting person is a director of Ovintiv Inc. and serves as its President & CEO.